SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders bought 51,835 put options on the company. This represents an increase of 41% compared to the typical daily volume of 36,668 put options.
SPDR S&P Biotech ETF Trading Down 2.6%
NYSEARCA XBI traded down $4.03 during trading on Tuesday, hitting $153.57. 6,286,593 shares of the company traded hands, compared to its average volume of 9,046,919. SPDR S&P Biotech ETF has a 12 month low of $93.26 and a 12 month high of $169.89. The business has a fifty day simple moving average of $158.20 and a 200 day simple moving average of $142.02. The company has a market capitalization of $10.03 billion, a P/E ratio of 11.47 and a beta of 0.84.
Institutional Trading of SPDR S&P Biotech ETF
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Axiom Investment Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $26,000. Financial Life Planners bought a new stake in SPDR S&P Biotech ETF in the first quarter worth approximately $27,000. Angeles Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $28,000. SHP Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $31,000. Finally, Greykasell Wealth Strategies Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $35,000.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
- Ready to Rumble: Anthropic Rings the AI Bell
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
